These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 6682318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
    Saborowski F, Dundalek E, Griebenow R, Sy M.
    Arzneimittelforschung; 1983; 33(2a):310-2. PubMed ID: 6682322
    [Abstract] [Full Text] [Related]

  • 5. [Animal experimental studies on the pharmacokinetics of carteolol].
    Lang W.
    Arzneimittelforschung; 1983; 33(2a):286-9. PubMed ID: 6682319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G, Veidt J, Mikludy R, Kaltenbach M.
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experiences in patients with coronary heart disease and angina pectoris].
    Sölter H.
    Arzneimittelforschung; 1983; 33(2a):304-10. PubMed ID: 6404286
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; 2006. PubMed ID: 30000575
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analytical profile of the new diuretic beta-blocking agent tienoxolol hydrochloride.
    Guechot C, Bertrand A, Cramaille P, Teulon JM.
    Arzneimittelforschung; 1988 May; 38(5):655-60. PubMed ID: 2901263
    [Abstract] [Full Text] [Related]

  • 15. Periodate oxidimetric determination of nadolol.
    Mohamed ME, Tawakkol MS, Aboul-Enein HY.
    Pharmazie; 1981 May; 36(7):516. PubMed ID: 6269122
    [No Abstract] [Full Text] [Related]

  • 16. [Metabolic fate of carteolol hydrochloride [5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride, OPC-1085], a new beta-blocker. V. Identification of metabolites in rat, dog and human (author's transl)].
    Mori H, Kido M, Murakami N, Morita S, Kohri H.
    Yakugaku Zasshi; 1977 Apr; 97(4):305-8. PubMed ID: 327055
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A cellulose derivative with a potential to become an active pharmaceutical substance as well as an auxiliary substance].
    Gajdziok J, Bajerová M, Chalupová Z, Masteiková R.
    Ceska Slov Farm; 2007 Dec; 56(6):259-63. PubMed ID: 18257415
    [Abstract] [Full Text] [Related]

  • 19. High-performance liquid chromatographic determination of oxprenolol hydrochloride and metoprolol tartrate in tablets and injections.
    Mehta AC.
    Analyst; 1982 Nov; 107(1280):1379-82. PubMed ID: 7181125
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and pharmacodynamic interactions among haloperidol, carteolol hydrochloride and biperiden hydrochloride.
    Isawa S, Murasaki M, Miura S, Yoshioka M, Uchiumi M, Kumagai Y, Aoki S, Hisazumi H, Kudo S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):111-8. PubMed ID: 10495985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.